AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.3631
-0.0198 (-5.17%)
At close: Jun 23, 2026, 4:00 PM EDT
0.3600
-0.0031 (-0.85%)
Pre-market: Jun 24, 2026, 8:11 AM EDT
AIM ImmunoTech Employees
As of December 31, 2025, AIM ImmunoTech had 21 total employees, including 19 full-time and 2 part-time employees. The number of employees decreased by 2 or -8.70% compared to the previous year.
Employees
21
Change (1Y)
-2
Growth (1Y)
-8.70%
Revenue / Employee
$4,476
Profits / Employee
-$632,190
Market Cap
8.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -2 | -8.70% | 19 | 2 |
| Dec 31, 2024 | 23 | -5 | -17.86% | 21 | 2 |
| Dec 31, 2023 | 28 | 4 | 16.67% | 26 | 2 |
| Dec 31, 2022 | 24 | 1 | 4.35% | 22 | 2 |
| Dec 31, 2021 | 23 | 0 | - | 21 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| MetaVia | 8 |
| Immuron | 7 |
| Cadrenal Therapeutics | 5 |
| Creative Medical Technology Holdings | 4 |
| Addex Therapeutics | 3 |
AIM News
- 18 hours ago - AIM Sports Group's National SoCal Cup ‘The Showcase' Event Serves Up a Weekend of New Experiences - Business Wire
- 1 day ago - AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series - GlobeNewsWire
- 5 days ago - AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer - GlobeNewsWire
- 6 days ago - AIM ImmunoTech Registration statement: Registration filing - Filings
- 7 days ago - AIM Talks China 2026 Convenes in Guangzhou, Advancing Strategic Partnerships and Cross Border Investment Across the Greater Bay Area - GlobeNewsWire
- 9 days ago - AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency - GlobeNewsWire
- 9 days ago - AIM ImmunoTech Proxy statement: Proxy filing - Filings
- 13 days ago - Infosys Collaborates with CMMI Institute to Shape Enterprise AI Maturity Framework; Achieves Milestone Recognition - PRNewsWire